Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores

Journal of Clinical and Experimental Hepatology

Volumn 1, Issue 3, 2011, Pages 161-168

  Chawla, Yogesh K ^a   Kashinath, Ramesh Chillal ^a   Duseja, Ajay ^a   Dhiman, Radha K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Child Turcotte Pugh score; Cirrhosis; Creatinine modified CTP; Model for end stage liver disease; Mortality; Outcome measures prognosis

Indexed keywords

CREATININE;

ACCURACY; ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CHILD TURCOTTE PUGH SCORE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE MODIFIED CHILD TURCOTTE PUGH SCORE; FEMALE; HUMAN; INDIAN; KIDNEY FAILURE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SURVIVAL RATE;

EID: 84856901517     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/S0973-6883(11)60233-8     Document Type: Article

References (32)

1. Freeman RB, Wiesner RH, Harper A, et al. UNOS/OPTN Liver Disease Severity Score, UNOS/OPTN Liver and Intestine, and UNOS/OPTN Pediatric Transplantation Committees. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002, 8:851-858.
2. Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001, 7:567-580.
3. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Ter Borg PC A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000, 31:864-871.
4. Salerno F, Merli M, Cazzaniga M, et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002, 36:494-500.
5. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001, 33:464-470.
6. Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004, 40:897-903.
7. Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gui 2003, 52:134-139.
8. Giannini E, Botta F, Fumagalli A, et al. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?. Liver Int 2004, 24:465-470.
9. Papatheodoridis GV, Cholongitas E, Dimitriadou E, Touloumi G, Sevastianos V, Archimandritis AJ MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis. World J Gastroenterol 2005, 11:3099-3104.
10. Schepke M, Roth F, Fimmers R, et al. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol 2003, 98:1167-1174.
11. Giannini E, Botta F, Testa R Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer. Gastroenterology 2003, 125:993-994.
12. Angermayr B, Cejna M, Karnel F, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003, 52:879-885.
13. Mishra P, Desai N, Alexander J, Singh DP, Sawant P Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience. J Gastroenterol Hepatol 2007, 22:1232-1235.
14. Shaikh S, Ghani H, Memon S, Baloch GH, Jaffery M, Shaikh K MELD era: is this time to replace the original Child-Pugh score in patients with decompensated cirrhosis of liver. J Coll Physicians Surg Pak 2010, 20:432-435.
15. Abouassi SG, Mihas A, Williams LM, et al. MELD and CTP scores are equivalent predictors of mortality in cirrhotic veterans referred for orthotopic liver transplantation (OLT). Hepatology 2001, 34:207A.
16. Sheth M, Riggs M, Patel T Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol 2002, 2:2.
17. Liado L, Figueras J, Memba R, et al. Is MELD really the definitive score for liver allocation?. Liver Transpl 2002, 8:795-798.
18. Forman LM, Lucey MR Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology 2001, 33:473-475.
19. Pagliaro L MELD: the end of Child-Pugh classification?. J Hepatol 2002, 36:141-142.
20. Christensen E, Krintel JJ, Hansen SM, Johansen JK, Juhl E Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis. Survival and prognostic factors. Scand J Gastroenterol 1989, 24:999-1006.
21. Llovet JM, Planas R, Morillas R, et al. Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: multivariate study. Am J Gastroenterol 1993, 88:388-392.
22. Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001, 34:46-52.
23. Prasad S, Dhiman RK, Duseja A, Chawla Y, Sharma A, Agarwal R Lactulose improves cognitive functions and health-related quality of life in cirrhotic patients with minimal hepatic encephalopathy. Hepatology 2007, 45:549-559.
24. Dhiman RK, Kurmi R, Thumburu KK, et al. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci 2010, 55:2381-2390.
25. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002, 35:716-721.
26. Dhiman RK, Makharia GK, Jain S, Chawla Y Ascites and spontaneous bacterial peritonitis in fulminant hepatic failure. Am J Gastroenterol 2000, 95:233-238.
27. Hanley JA, McNeil BJ The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143:29-36.
28. Hanley JA, McNeil BJ A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983, 148:839-843.
29. Guo Z, He X, Wu L, et al. Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients. Surg Today 2010, 40:38-45.
30. Saab S, Niho H, Comulada S, et al. Mortality predictors in liver transplant recipients with recurrent hepatitis C cirrhosis. Liver Int 2005, 25:940-945.
31. Wiesner R, Edwards E, Freeman R, et al. United Network for Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003, 124:91-96.
32. Huo Tl, Lin HC, Lee FY, et al. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline modelforend-stage liver disease score. Liver Int 2006, 26:55-61.